Oral antibacterial material as well as preparation method and application thereof

By using antibacterial materials combined with C16N-DCA in the oral cavity, the charge reversal mechanism in the acidic environment is used to solve the problem that existing antibacterial agents cannot act continuously, and the caries and periodontal treatments are achieved Effective prevention and treatment of diseases.

CN118903186AActive Publication Date: 2024-11-08BEIJING UNIV OF CHEM TECH +1
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411061029.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-08
Estimated Expiration
2044-08-05

AI Technical Summary

Technical Problem

The existing antibacterial agents cannot achieve continuous antibacterial effects due to the rapid removal of saliva in the oral cavity, making it difficult to effectively prevent and treat caries and periodontal diseases.

Method used

Using CMCS-Mal and CMCS-NAC as main components, combined with C16N-DCA, an acid-unstable structure is formed through amide bonds, pH-induced release of antibacterial drugs is achieved, controllable adhesion antibacterial materials are designed, and C16N-DCA is used in an acidic environment. The charge in the middle is reversed, destroying the biofilm and achieving antibacterial effect.

Benefits of technology

It provides a controlled release oral antibacterial material that can effectively destroy biofilms in an acidic environment, significantly improve the antibacterial effect of drugs, and improve the defense ability of oral infection through improved adhesion and biocompatibility.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903186A_ABST
    Figure CN118903186A_ABST
Patent Text Reader

Abstract

The invention provides an oral cavity antibacterial material, which comprises a component A and a component B. The component A comprises 5-9 wt% of CMCS-Mal and 0.1-0.5 wt% of C16N-DCA; and the component B is prepared from 2 to 5 weight percent of CMCS-NAC (Carboxymethyl Cellulose Sulfonate- According to the present invention, the CMCS-Mal, the CMCS-NAC and the C16N-DCA are adopted as the raw materials to prepare the sprayable wet adhesion material with characteristics of controllable adhesion, rapid gel forming and antibacterial property;
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of medical supplies, and in particular to an oral antibacterial material and a preparation method and application thereof. Background Art

[0002] Most persistent infectious diseases in humans are caused by virulent biofilms, including those occurring in the oral cavity, such as caries and periodontal disease. In the oral cavity, cariogenic (cariogenic) biofilms accumulate on teeth covered with a membrane as a matrix rich in exopolysaccharides (EPS) that rapidly develops in the presence of dietary sucrose. Bacteria ferment in the EPS matrix, creating a highly acidic microenvironment. In human dental biofilms (also known as plaque), pH values ​​often reach 4.5 or even lower, and persistent acidic plaque can lead to caries. Current topically introduced antimicrobial agents cannot achieve a sustained antimicrobial effect due to rapid clearance by saliva.

[0003] Therefore, it is necessary to develop new treatments for oral biofilms. Summary of the invention

[0004] In order to solve at least one of the above technical problems, in the first aspect of the present application, the present application provides an oral antibacterial material, comprising component A and component B, wherein component A comprises 5-9 wt % CMCS-Mal, 0.1-0.5 wt % C 16 N-DCA; the B component includes 2-5 wt % of CMCS-NAC.

[0005] Preferably, the A component comprises 5-9 wt % of CMCS-Mal, 0.5 wt % of C 16 N-DCA; the B component includes 3 wt % of CMCS-NAC.

[0006] Preferably, the A component comprises 9 wt % of CMCS-Mal, 0.5 wt % of C 16 N-DCA; the B component includes 3wt% of CMCS-NAC.

[0007] Preferably, the preparation method of the CMCS-Mal comprises: dissolving CMCS in a buffer solution, adding NHS, EDC and Mal-HCl, adjusting the pH to 5-6, reacting in the dark, purifying the product by membrane dialysis, and freeze-drying to obtain the CMCS-Mal.

[0008] Preferably, the C 16 The preparation method of N-DCA comprises: 16 H 35N and 1,2-dicarboxylic acid-cyclohexene anhydride were added to DCM, reacted, the solvent was evaporated, washed with water, and dried to obtain the C 16 N-DCA.

[0009] Preferably, the preparation method of the CMCS-NAC comprises: dissolving CMCS in a buffer solution, adding NHS, EDC and NAC, adjusting the pH to 5-6, reacting in the dark, purifying the product by membrane dialysis, and freeze-drying to obtain the CMCS-NAC.

[0010] Preferably, the solvents used in the components A and B are both mixed solvents consisting of glycerol and water, and the volume ratio of glycerol to water in the solvents used in the components A and B is 3:100.

[0011] In a second aspect of the present application, the present application provides a method for preparing the oral antibacterial material according to the first aspect of the present invention, comprising: preparing a CMCS-Mal solution with a concentration of 5-9 wt %, adding C 16 N-DCA, Control C 16 The concentration of N-DCA is 0.1-0.5 wt %, and the mixture is mixed evenly to obtain the A component; and a CMCS-NAC solution with a concentration of 2-5 wt % is prepared to obtain the B component.

[0012] In the third aspect of the present application, the present application provides a method for using the oral antibacterial material described in the first aspect of the present invention, comprising: spraying component A on a target position in the oral cavity, and then spraying component B.

[0013] In a fourth aspect of the present application, the present application provides a use of the oral antibacterial material described in the first aspect of the present invention in preparing an antibacterial material.

[0014] The amide bond is an acid-labile structure that can endow the drug delivery system with charge reversal properties to achieve pH-induced release of antimicrobial drugs. 16 N-DCA) to achieve controllable antibacterial, C 16 N-DCA can reverse its charge to a cationic structure in an acidic environment. The introduction of the cationic structure leads to the destruction of the biofilm framework and biofilm phase separation, and then long-chain carbon enters the biofilm to achieve an antibacterial effect.

[0015] Biomaterials can be precisely controlled to obtain direct bactericidal activity or improve drug delivery efficiency, and at the same time have sufficient flexibility to reach small areas or hard-to-reach areas of the oral microstructure. Natural polymers have many advantages such as wide sources, good biocompatibility, and on-demand functional modification. Compared with chitosan, carboxymethyl chitosan (CMCS) has increased water solubility and pH sensitivity. Its chemotaxis to neutrophils and macrophages helps prevent oral infections and is one of the commonly used raw materials for preparing antibacterial dressings. N-acetylcysteine ​​(NAC) is an antioxidant and anti-inflammatory amino acid derivative. The thiol group in its structure can form a disulfide bond with the cysteine-rich glycoprotein subdomains in the oral tissue. Therefore, by grafting thiol groups on carboxymethyl chitosan, the adhesion ability of the gel material can be significantly improved. In order to adapt to the oral environment, CMCS was modified to synthesize maleimide carboxymethyl chitosan (CMCS-Mal) and N-acetylcysteine ​​carboxymethyl chitosan (CMCS-NAC). CMCS-Mal and CMCS-NAC were sprayed into the oral cavity respectively and could quickly cross-link to form gel materials.

[0016] In summary, the present invention includes at least one of the following beneficial technical effects: 1. The present invention provides an oral antibacterial material comprising CMCS-Mal, CMCS-NAC and C 16 N-DCA is used as a raw material to prepare a sprayable wet adhesive material with controllable adhesion, rapid gelation and antibacterial properties.

[0017] 2. The present invention provides an oral antibacterial material, by adjusting CMCS-Mal, C 16 The concentration of N-DCA and the concentration of CMCS-NAC in liquid B achieve the optimal antibacterial effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 CNM-C prepared in Example 1 16 The adhesion effect of N on pig tissue; Figure 2 C prepared in Example 1 16 Infrared images of N-DCA hydrolysis in different pH environments; Figure 3 The blank control (control) was used, and no C was added. 16 The hydrogel group (CNM) of N-DCA and the CNM-C prepared in Example 1 of the present invention 16 N gel (CNM-C 16 Comparison of the antibacterial patterns of Gram-positive bacteria (e.g. Staphylococcus aureus) in the plate spreading method between the positive control antibiotic group (N) and the positive control antibiotic group (vancomycin hydrochloride); Figure 4The blank control (control) was used, and no C was added. 16 The hydrogel group (CNM) of N-DCA and the CNM-C prepared in Example 1 of the present invention 16 N gel (CNM-C 16 Comparison of SEM images of the positive control antibiotic group (vancomycin hydrochloride) and the positive control antibiotic group (vancomycin hydrochloride) on Gram-positive bacteria (taking Staphylococcus aureus as an example); Figure 5 The blank control (control) was used, and no C was added. 16 The hydrogel group (CNM) of N-DCA and the CNM-C prepared in Example 1 of the present invention 16 N gel (CNM-C 16 Laser confocal images of biofilms of N) and positive control antibiotic group (vancomycin hydrochloride) against Gram-positive bacteria (taking Staphylococcus aureus as an example); Among them, the upper SYTO9 is before the hydrogel effect, and the lower PI is after the hydrogel effect; Figure 6 The antibacterial data of Examples 1-9 are shown in FIG. DETAILED DESCRIPTION

[0019] The present invention will be further described below in conjunction with specific examples and accompanying drawings, but the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. In the following examples, if specific conditions are not specified, they are carried out according to normal conditions or conditions recommended by the manufacturer. The methods used are conventional methods known in the art unless otherwise specified, and the consumables and reagents used are commercially available unless otherwise specified. Unless otherwise specified, the professional and scientific terms used herein have the same meaning as those familiar to those skilled in the art. In addition, any method or material similar or equivalent to the recorded content may also be applied to the present invention. Specific embodiments Example 1

[0020] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add N-hydroxysuccinimide (NHS, 15 mmol, 1.725 g), 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC, 15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0021] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and 5-aminolevulinic acid methyl ester hydrochloride (Mal-HCl, 15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0022] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0023] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 5 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.1 wt %, named as liquid A; ② Prepare 10 mL of 1 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named as liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered.

[0024] Figure 1 CNM-C prepared in Example 1 16 The adhesion effect of CNM-C on pig tissues; 16 N gel can firmly adhere to the moist tissue environment and remains firmly adhered even after external forces, providing long-term treatment for the oral cavity.

[0025] Figure 2 C prepared in Example 1 16 Infrared images of N-DCA hydrolysis in different pH environments; it can be seen from the figure that C 16 N-DCA can be hydrolyzed in the acidic oral microenvironment to produce long-chain quaternary ammonium salt C16 NH3 + , which can target antibacterial effects in the oral environment but has no biological toxicity in other neutral microenvironments.

[0026] Figure 3 The blank control (control) was used, and no C was added. 16 The hydrogel group (CNM) of N-DCA and the CNM-C prepared in Example 1 of the present invention 16 N gel (CNM-C 16 Comparison of the antibacterial patterns of Gram-positive bacteria (e.g. Staphylococcus aureus) in the plate spreading method between the positive control antibiotic group (N) and the positive control antibiotic group (vancomycin hydrochloride); Figure 4 The blank control (control) was used, and no C was added. 16 The hydrogel group (CNM) of N-DCA and the CNM-C prepared in Example 1 of the present invention 16 N gel (CNM-C 16 Comparison of SEM images of the positive control antibiotic group (vancomycin hydrochloride) and the positive control antibiotic group (vancomycin hydrochloride) on Gram-positive bacteria (taking Staphylococcus aureus as an example); Figure 5 The blank control (control) was used, and no C was added. 16 The hydrogel group (CNM) of N-DCA and the CNM-C prepared in Example 1 of the present invention 16 N gel (CNM-C 16 N) and the positive control antibiotic group (vancomycin hydrochloride) against Gram-positive bacteria (Staphylococcus aureus as an example) biofilm laser confocal image; the upper SYTO9 is before the hydrogel effect, and the lower PI is after the hydrogel effect; No C added 16 The N-DCA hydrogel group (CNM) was similar to the CNM-C prepared in Example 1. 16 The only difference between N gel and N gel is that no C 16 N-DCA, positive control with an equal amount of vancomycin hydrochloride instead of CNM-C 16 N gel. Example 2

[0027] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0028] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0029] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0030] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 7 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.1 wt %, named as liquid A; ② Prepare 10 mL of 1 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named as liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 3

[0031] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0032] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0033] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0034] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.1 wt %, named as liquid A; ② Prepare 10 mL of 1 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named as liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 4

[0035] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0036] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0037] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0038] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.3 wt %, named as liquid A; ② Prepare 10 mL of 1 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 5

[0039] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0040] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0041] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexenoic anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0042] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.3 wt %, named as liquid A; ② Prepare 10 mL of 3 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 6

[0043] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0044] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0045] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0046] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.3 wt %, named as liquid A; ② Prepare 10 mL of 5 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 7

[0047] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0048] (2) Preparation of CMCS-Mal ① Hexadecylamine (C 16 N, 10 mmol) was dissolved in 200 mL MES buffer solution; ② NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g) were then added, and the pH value of the above solution was maintained at 5.5 in the dark for 24 h; ③ After the reaction was completed, the product was purified by membrane dialysis and the obtained product was freeze-dried and stored.

[0049] (3) Preparation of C 16 N-DCA ①C 16 H 35 ② Add N (0.1 mmol, 24.1 mg) and 1,2-dicarboxylic acid-cyclohexenoic anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the obtained product in an oven.

[0050] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.5 wt %, named as liquid A; ② Prepare 10 mL of 1 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 8

[0051] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0052] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0053] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0054] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.5 wt %, named as liquid A; ② Prepare 10 mL of 3 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered. Example 9

[0055] (1) Preparation of CMCS-NAC ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and NAC (15 mmol, 2.45 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0056] (2) Preparation of CMCS-Mal ① Dissolve CMCS (10 mmol) in 200 mL MES buffer solution; ② Then add NHS (15 mmol, 1.725 g), EDC (15 mmol, 2.87 g) and Mal-HCl (15 mmol, 2.24 g), keep the pH value of the above solution at 5.5 and react in the dark for 24 h; ③ After the reaction is completed, purify the product by membrane dialysis and freeze-dry it for storage.

[0057] (3) Preparation of C 16 N-DCA ① Hexadecylamine (C 16 H 35 ② Add 1,2-dicarboxylic acid-cyclohexene anhydride (DCA, 15.2 mg, 0.1 mmol) into anhydrous DCM (10 mL); ② Stir the reaction at room temperature for 0.5 h; ③ Evaporate the solvent under reduced pressure to obtain a white solid product; ④ Wash with water to remove unreacted DCA, and store the product in an oven.

[0058] (4) Preparation of CNM-C 16 N Gel ① Prepare 10 mL of 9 wt % CMCS-Mal glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100. 16 N-DCA is evenly dispersed in the CMCS-Mal glycerol aqueous solution to control C 16 The concentration of N-DCA is 0.5 wt %, named as liquid A; ② Prepare 10 mL of 5 wt % CMCS-NAC glycerol aqueous solution at room temperature, where glycerol: water (V / V) = 3:100, named liquid B. When in use, spray liquid A on the plaque position of oral teeth, and then spray liquid B. The two will quickly gel after contact. Liquid A and liquid B are sprayed at a ratio of 1:1, and the specific spraying dosage is based on the size of the plaque covered.

[0059] CNM-C prepared by mixing solution A and solution B in Example 1-9 at a volume ratio of 1:1 16 N gel and bacterial solution (10 6 CFU mL -1 , Staphylococcus aureus) and incubated at 37°C for 5 h. A blank control was set up at the same time. After the bacteria grew for 20 h, the number of bacteria grown was counted using the plate counting method, and the inhibition rate was calculated. The results are shown in Table 1. Figure 6 shown.

[0060] Table 1 Antibacterial rate results of Examples 1-9 Antibacterial rate / % Example 1 85.93 Example 2 82.11 Example 3 80.45 Example 4 87.64 Example 5 89.99 Example 6 91.65 Example 7 93.95 Example 8 95.32 Example 9 94.75 Depend on Figure 6 As shown in Table 1, the CMCS-Mal and C 16 The concentration of N-DCA and the concentration of CMCS-NAC in solution B can increase the 16 Antibacterial effect of N gel.

[0061] The above are all preferred embodiments of the present application, and the protection scope of the present application is not limited thereto. Therefore, any equivalent changes made according to the structure, shape, and principle of the present application should be included in the protection scope of the present application.

Claims

1. An oral antibacterial material, characterized in that: The invention comprises component A and component B, wherein component A comprises 5-9 wt % of CMCS-Mal, 0.1-0.5 wt % of C 16 N-DCA; the B component includes 2-5 wt % of CMCS-NAC.

2. The oral antibacterial material according to claim 1, characterized in that: The A component includes 5-9 wt % CMCS-Mal, 0.5 wt % C 16 N-DCA; the B component includes 3 wt % of CMCS-NAC.

3. The oral antibacterial material according to claim 1, characterized in that: The A component includes 9 wt % CMCS-Mal, 0.5 wt % C 16 N-DCA; the B component includes 3 wt % of CMCS-NAC.

4. The oral antibacterial material according to claim 1, characterized in that: The preparation method of the CMCS-Mal comprises: dissolving CMCS in a buffer solution, adding NHS, EDC and Mal-HCl, adjusting the pH to 5-6, reacting in the dark, purifying the product by membrane dialysis, and freeze-drying to obtain the CMCS-Mal.

5. The oral antibacterial material according to claim 1, characterized in that: The C 16 The preparation method of N-DCA comprises: 16 H 35 N and 1,2-dicarboxylic acid-cyclohexene anhydride were added to DCM, reacted, the solvent was evaporated, washed with water, and dried to obtain the C 16 N-DCA.

6. The oral antibacterial material according to claim 1, characterized in that: The preparation method of the CMCS-NAC comprises: dissolving CMCS in a buffer solution, adding NHS, EDC and NAC, adjusting the pH to 5-6, reacting in the dark, purifying the product by membrane dialysis, and freeze-drying to obtain the CMCS-NAC.

7. The oral antibacterial material according to claim 1, characterized in that: The solvents used in the components A and B are both mixed solvents consisting of glycerol and water, and the volume ratio of glycerol to water in the solvents used in the components A and B is 3:

100.

8. A method for preparing an oral antibacterial material according to any one of claims 1 to 7, characterized in that: include: Prepare a CMCS-Mal solution with a concentration of 5-9 wt %, add C 16 N-DCA, Control C 16 The concentration of N-DCA is 0.1-0.5 wt %, and the mixture is mixed evenly to obtain the A component; and a CMCS-NAC solution with a concentration of 2-5 wt % is prepared to obtain the B component.

9. A method for using the oral antibacterial material according to any one of claims 1 to 7, characterized in that: include: After spraying component A on the target location in the mouth, spray component B.

10. Use of the oral antibacterial material according to any one of claims 1 to 7 in the preparation of antibacterial materials.

Citation Information

Patent Citations

  • Hydrate inhibitor carrying hydrogel

    CN107849435A

  • High-strength green degradable antibacterial biomass composite membrane as well as preparation method and application thereof

    CN115536882A

  • Hydrogel for alimentary canal ESD (Electro-Static Discharge) as well as preparation method and application thereof

    CN115991883A

  • Acid-wet-resistant adhesion dressing

    CN117045854A

  • Preparation method of tumor weak acid driven charge reversal amphiphilic molecule

    CN117623974A